Combination therapy

Details for Australian Patent Application No. 2004294786 (hide)

Owner The Queen's University of Belfast

Inventors Johnston, Patrick Gerard; Longley, Daniel

Agent Wrays

Pub. Number AU-A-2004294786

PCT Pub. Number WO2005/053739

Priority 0327493.3 26.11.03 GB

Filing date 26 November 2004

Wipo publication date 16 June 2005

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053739 Priority application(s): WO2005/053739

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294790-DNA damage repair inhibitors for treatment of cancer

2004294784-Novel imaging agents comprising caspase-3 inhibitors